Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tacrolimus for desquamative gingivitis
ACTRN12609000125224Phase 3Not yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Sep 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tacrolimus in Desquamative Gingivitis (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Clinical effectiveness based on oral signs and symptoms. Planned start Sep 2008; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
Desquamative Gingivitis
Beyond the preview
Go deeper on ACTRN12609000125224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000125224.